investorscraft@gmail.com

Intrinsic ValueChiyoda Integre Co.,Ltd. (6915.T)

Previous Close¥3,305.00
Intrinsic Value
Upside potential
Previous Close
¥3,305.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Chiyoda Integre Co., Ltd. operates as a specialized manufacturer of structural and functional components, serving diverse industries including office automation, automotive, telecommunications, and home appliances. The company’s product portfolio spans precision parts such as insulation materials, shielding components, and LED lighting solutions, alongside niche offerings like medical-grade antimicrobial agents and surgical sponge processing. Its vertically integrated capabilities—from pressed products to skin sewing—allow for tailored solutions that cater to both industrial and consumer applications. Positioned in Japan’s competitive hardware and equipment sector, Chiyoda Integre differentiates itself through technical expertise in material science and a diversified client base that mitigates sector-specific risks. While its domestic market remains core, international operations contribute to revenue resilience. The firm’s focus on high-margin niche segments, such as medical and LED components, underscores its strategic shift toward value-added manufacturing amid broader industry commoditization pressures.

Revenue Profitability And Efficiency

For FY 2024, Chiyoda Integre reported revenue of ¥41.2 billion, with net income of ¥3.2 billion, reflecting a net margin of approximately 7.8%. Operating cash flow stood at ¥5.2 billion, supported by disciplined cost management, while capital expenditures of ¥1.4 billion indicate moderate reinvestment. The company’s cash conversion efficiency appears robust, with operating cash flow covering capex nearly four times over.

Earnings Power And Capital Efficiency

Diluted EPS of ¥310.86 highlights the firm’s earnings stability, bolstered by its diversified product mix. The modest debt-to-equity ratio, inferred from total debt of ¥1.4 billion against cash reserves of ¥18.2 billion, suggests strong capital efficiency and low financial leverage. This positions the company to fund growth initiatives organically while maintaining liquidity buffers.

Balance Sheet And Financial Health

Chiyoda Integre’s balance sheet remains solid, with ¥18.2 billion in cash and equivalents dwarfing its ¥1.4 billion total debt. This liquidity profile, coupled with negligible leverage, provides ample flexibility for strategic investments or shareholder returns. The absence of significant debt maturities near-term further reduces financial risk.

Growth Trends And Dividend Policy

The company’s growth trajectory is tempered by its mature domestic market, though international segments and niche products like medical components offer incremental opportunities. A dividend of ¥160 per share signals a commitment to returning capital, with a payout ratio of roughly 51% of net income, balancing reinvestment needs with shareholder expectations.

Valuation And Market Expectations

At a market cap of ¥26.3 billion, the stock trades at a P/E of ~8.1x based on FY 2024 earnings, reflecting modest growth expectations. A beta of 0.155 suggests low volatility relative to the broader market, aligning with its stable but slow-growth profile.

Strategic Advantages And Outlook

Chiyoda Integre’s competitive edge lies in its technical specialization and diversified industrial exposure, which insulate it from cyclical downturns in any single sector. Near-term challenges include cost pressures from raw materials and global supply chain disruptions, but its strong balance sheet and focus on high-margin niches position it for steady, if unspectacular, performance.

Sources

Company filings, market data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount